SCHEMBL31708134

SCHEMBL31708134

CNC(=O)C(=O)c1c[nH]c2cccc(OC(C)=O)c12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC22A6 Q4U2R8 1/20 0.47
▸ NR4A2 P43354 2/20 0.43
▸ MTNR1A P48039 1/20 0.40
▸ MTNR1B P49286 1/20 0.40
▸ PBRM1 Q86U86 1/20 0.40
▸ ALOX5 P09917 1/20 0.39
▸ MAPK1 P28482 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ ESR1 P03372 1/20 0.38
▸ ITGB3 P05106 1/20 0.38
▸ ITGA2B P08514 1/20 0.38
▸ HMGB1 P09429 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ GGT1 P19440 1/20 0.38
▸ PTGS1 P23219 1/20 0.38
▸ PTGS2 P35354 1/20 0.38
▸ BLM P54132 1/20 0.38
▸ NAPRT Q6XQN6 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30276861 0.86 ALOX5 (0.44) SLC22A6NR4A2MTNR1AMTNR1BALOX5
SCHEMBL31708138 0.86 SLC22A6 (0.44) SLC22A6NR4A2MTNR1AMTNR1BALOX5
SCHEMBL30712078 0.85 SLC22A6 (0.50) SLC22A6NR4A2MTNR1AMTNR1BPBRM1
SCHEMBL31708098 0.84 ALOX5 (0.43) SLC22A6NR4A2MTNR1AMTNR1BALOX5
SCHEMBL31708071 0.84 RAB9A (0.52) SLC22A6NR4A2MTNR1AMTNR1BHSD17B10
SCHEMBL20898149 0.84 SLC22A6 (0.49) SLC22A6NR4A2MTNR1AMTNR1BPBRM1
SCHEMBL29504147 0.84 SLC22A6 (0.49) SLC22A6NR4A2MTNR1AMTNR1BPBRM1
SCHEMBL25792506 0.83 SLC22A6 (0.58) SLC22A6NR4A2MTNR1AMTNR1BPBRM1
SCHEMBL31708212 0.83 MAPT (0.44) SLC22A6MTNR1AMTNR1BALOX5RAB9A
SCHEMBL31708107 0.82 ALOX5 (0.41) SLC22A6NR4A2MTNR1AMTNR1BALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4635492-A2 TRYPTAMINES AND METHODS OF TREATING MOOD DISORDERS Gilgamesh Pharmaceuticals, Inc. (US) 2025-10-22 — — EP disclosed
Send feedback